In March 2013, diagnosis of the first reported case of human infection with a novel avian-origin
influenza A(H7N9) virus occurred in eastern China. Most human cases have resulted in …

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated in
Wuhan, China in late 2019, and its resulting coronavirus disease, COVID-19, was declared a …

We evaluated the performance of the BioFire® Respiratory Panel 2.1 (RP2.1) in the detection
of SARS CoV-2 in comparison against three other SARS CoV-2 EUA assays. In these …

Although influenza viruses typically cause respiratory tract disease, some viruses, particularly
those with an H7 hemagglutinin, have been isolated from the eyes of conjunctivitis cases. …

Lack of evidence on SARS-CoV-2 transmission dynamics has led to shifting isolation
guidelines between airborne and droplet isolation precautions. During the initial isolation of 13 …

A novel highly pathogenic avian influenza (HPAI) H5N8 virus, first detected in January 2014
in poultry and wild birds in South Korea, has spread throughout Asia and Europe and …

In December 2016, a low-pathogenic avian influenza (LPAI) A(H7N2) virus was identified to
be the causative source of an outbreak in a cat shelter in New York City, which subsequently …

Avian influenza A (H5N1) viruses represent a growing threat for an influenza pandemic. The
presence of widespread avian influenza virus infections further emphasizes the need for …

The fifth wave of the H7N9 influenza epidemic in China was distinguished by a sudden increase
in human infections, an extended geographic distribution, and the emergence of highly …

As influenza A viruses (IAV) continue to cross species barriers and cause human infection,
the establishment of risk assessment rubrics has improved pandemic preparedness efforts. In …